Ajinomoto’s future P/E and net profit margin have both remained virtually unchanged, supporting a stable outlook and leading to only a slight increase in the consensus analyst price target from ¥4185 to ¥4255.
What's in the News
- Ajinomoto, in partnership with Solar Foods, launched Solein®-powered Flowering Ice Cream and other products under its Atlr.72™ brand at the World Aquatics Championships in Singapore, promoting a healthy and environmentally conscious food lifestyle.
- The Solein® protein ingredient, produced via microbial fermentation, is positioned as a sustainable, nutritious protein alternative for various food products.
- From May 8 to June 30, 2025, Ajinomoto completed the repurchase of 14,658,600 shares (1.47%) for ¥46,613.69 million under its announced buyback program.
Valuation Changes
Summary of Valuation Changes for Ajinomoto
- The Consensus Analyst Price Target remained effectively unchanged, moving only marginally from ¥4185 to ¥4255.
- The Future P/E for Ajinomoto remained effectively unchanged, moving only marginally from 27.55x to 27.92x.
- The Net Profit Margin for Ajinomoto remained effectively unchanged, moving only marginally from 8.78% to 8.83%.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.